49 results
Page 3 of 3
10-Q
x6t6k6i
8 Nov 22
Quarterly report
4:09pm
8-K
EX-1.1
of8rdla yo7798oq2u4u
21 Oct 22
Entry into a Material Definitive Agreement
4:19pm
424B5
a8ft3thftz8n6i9q
21 Oct 22
Prospectus supplement for primary offering
4:16pm
8-K
EX-99.1
w3o5s
19 Oct 22
Jazz Pharmaceuticals and Zymeworks Announce Exclusive License Agreement to Develop and Commercialize Zanidatamab, a HER2-Targeted Bispecific Antibody
6:26am
424B5
37t69y9d2zr14y21tcl
13 Oct 22
Prospectus supplement for primary offering
4:56pm
8-K12B
EX-14.1
5gr5e
13 Oct 22
Notification of registration of securities
7:24am
424B3
qcauw4arufb3jplyx8h9
2 Sep 22
Prospectus supplement
4:06pm
S-4/A
1jwlbsvj176
19 Aug 22
Registration of securities issued in business combination transactions (amended)
4:47pm
S-4
mtedlyd uxh9u7nojm
15 Jul 22
Registration of securities issued in business combination transactions
4:04pm